Sourcebio International Plc (LON:SBI – Get Rating)’s share price shot up 4.5% during trading on Tuesday . The company traded as high as GBX 125 ($1.57) and last traded at GBX 115 ($1.44). 1,571,282 shares were traded during mid-day trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.38).
Sourcebio International Trading Up 4.5 %
The company has a market cap of £85.31 million and a price-to-earnings ratio of 1,277.78. The company has a debt-to-equity ratio of 35.10, a current ratio of 1.91 and a quick ratio of 1.78. The firm’s fifty day moving average price is GBX 115 and its 200-day moving average price is GBX 113.40.
About Sourcebio International
Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.
See Also
- How to Calculate Stock Growth
- 7 Best Retail Stocks to Invest in
- 3 Home Improvement Stocks to Renovate Your Portfolio
- Beam Global Shines Brightly in the EV Infrastructure Space
- Canoo Bottoms As Production Ramp Gets Closer
Receive News & Ratings for Sourcebio International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sourcebio International and related companies with MarketBeat.com's FREE daily email newsletter.
